Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate plus simvastatin versus simvastatin alone in mixed dyslipidemia after simvastatin run-in
ACTRN12605000777695Phase 3Not yet recruiting
- Sponsor
- Viatris
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of fenofibrate and simvastatin in combined dyslipidaemia (2 arms), sponsored by Viatris. Primary endpoints: Triglycerides and LDL-C. Planned start Dec 2005; status: not yet recruiting.
02
Drugs
fenofibratesimvastatin
03
Conditions
combined dyslipidaemia
Beyond the preview
Go deeper on ACTRN12605000777695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12605000777695.